These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

78 related items for PubMed ID: 6274534

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A phase I trial of amifostine (WR-2721) and melphalan in children with refractory cancer.
    Adamson PC, Balis FM, Belasco JE, Lange B, Berg SL, Blaney SM, Craig C, Poplack DG.
    Cancer Res; 1995 Sep 15; 55(18):4069-72. PubMed ID: 7664282
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Phase I clinical studies with WR-2721.
    Kligerman MM, Shaw MT, Slavik M, Yuhas JM.
    Cancer Clin Trials; 1980 Sep 15; 3(3):217-21. PubMed ID: 6254682
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Combined-modality therapy for esophageal cancer: phase I trial of escalating doses of paclitaxel in combination with cisplatin, 5-fluorouracil, and high-dose radiation before esophagectomy.
    Weiner LM, Colarusso P, Goldberg M, Dresler C, Coia LR.
    Semin Oncol; 1997 Dec 15; 24(6 Suppl 19):S19-93-S19-95. PubMed ID: 9427276
    [Abstract] [Full Text] [Related]

  • 10. Adverse effects of radioprotector WR2721.
    Cairnie AB.
    Radiat Res; 1983 Apr 15; 94(1):221-6. PubMed ID: 6304804
    [Abstract] [Full Text] [Related]

  • 11. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
    Colón-Otero G, Marschke R, Camoriano JK, Sorensen JM, Sloan JA, Richardson RL.
    Cancer J Sci Am; 1997 Apr 15; 3(5):297-302. PubMed ID: 9327154
    [Abstract] [Full Text] [Related]

  • 12. Phase I clinical and pharmacokinetic study of carzelesin (U-80244) given daily for five consecutive days.
    Wolff I, Bench K, Beijnen JH, Bruntsch U, Cavalli F, de Jong J, Groot Y, van Tellingen O, Wanders J, Sessa C.
    Clin Cancer Res; 1996 Oct 15; 2(10):1717-23. PubMed ID: 9816122
    [Abstract] [Full Text] [Related]

  • 13. Upper hemibody and local chest irradiation as consolidation following response to high-dose induction chemotherapy for small cell bronchogenic carcinoma--a pilot study.
    Mason BA, Richter MP, Catalano RB, Creech RB.
    Cancer Treat Rep; 1982 Aug 15; 66(8):1609-12. PubMed ID: 6286119
    [Abstract] [Full Text] [Related]

  • 14. Phase I studies of combined paclitaxel/epirubicin and paclitaxel/epirubicin/cyclophosphamide in patients with metastatic offast cancer: the French experience.
    Catimel G, Spielmann M, Dieras V, Tubiana-Hulin M, Bonneterre J, Pouillart P, Kayitalire L, Guastalla JP, Graffand N, Garet F, Dumortier A, Pellae-Cosset B.
    Semin Oncol; 1997 Feb 15; 24(1 Suppl 3):S8-12. PubMed ID: 9071333
    [Abstract] [Full Text] [Related]

  • 15. Rationale for initial clinical trials and future development of radioprotectors.
    Phillips TL.
    Cancer Clin Trials; 1980 Feb 15; 3(2):165-73. PubMed ID: 6253097
    [Abstract] [Full Text] [Related]

  • 16. Clinical trials of WR-2721 with radiation therapy.
    Blumberg AL, Nelson DF, Gramkowski M, Glover D, Glick JH, Yuhas JM, Kligerman MM.
    Int J Radiat Oncol Biol Phys; 1982 Feb 15; 8(3-4):561-3. PubMed ID: 6286554
    [Abstract] [Full Text] [Related]

  • 17. Final report on phase I trial of WR-2721 before protracted fractionated radiation therapy.
    Kligerman MM, Turrisi AT, Urtasun RC, Norfleet AL, Phillips TL, Barkley T, Rubin P.
    Int J Radiat Oncol Biol Phys; 1988 Jun 15; 14(6):1119-22. PubMed ID: 2454903
    [Abstract] [Full Text] [Related]

  • 18. Phase I trial of pentamethylmelamine in patients with previously treated malignancies.
    Van Echo DA, Chiuten DF, Whitacre M, Aisner J, Lichtenfeld JL, Wiernik PH.
    Cancer Treat Rep; 1980 Jun 15; 64(12):1335-9. PubMed ID: 6781747
    [Abstract] [Full Text] [Related]

  • 19. Phase I clinical and pharmacological study of liposome-entrapped NDDP administered intrapleurally in patients with malignant pleural effusions.
    Perez-Soler R, Shin DM, Siddik ZH, Murphy WK, Huber M, Lee SJ, Khokhar AR, Hong WK.
    Clin Cancer Res; 1997 Mar 15; 3(3):373-9. PubMed ID: 9815694
    [Abstract] [Full Text] [Related]

  • 20. A phase I/II study of paclitaxel plus cisplatin as first-line therapy for head and neck cancers: preliminary results.
    Hitt R, Hornedo J, Colomer R, Mendiola C, Brandariz A, Sevilla E, Alvarez-Vicent J, Cortés-Funes H.
    Semin Oncol; 1995 Dec 15; 22(6 Suppl 15):50-4. PubMed ID: 8643971
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.